drugset / Trial / NCT00062972

Improving Memory in Patients With Multiple Sclerosis

NCT00062972

RandomizedParallel-groupDouble-blindTreatment

Summary

People with multiple sclerosis (MS) suffer from cognitive and other brain problems. This study will examine the effectiveness of the drug donepezil and of sugar water for enhancing memory in individuals with MS. Donepezil (also known as Aricept) has been FDA approved for improving memory and learning in individuals with Alzheimer's disease.

Timeline

Start
1999-09
Primary completion
Completion
2002-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule
Subject Glucose Unknown

Indications